Cancer recurrence remains a great fear for many cancer survivors following their initial,
apparently successful, therapy. Despite significant improvement in the overall survival of …

Metastasis and relapse account for the great majority of cancer-related deaths. Most
metastatic lesions are micro metastases that have the capacity to remain in a non-dividing …

A gender discrepancy exists in the incidence of both urothelial and kidney carcinomas, with
more men presenting with these cancers than women. Men have a threefold greater risk of …

Background Optimal follow-up (FU) strategy to detect potentially curable (PC) recurrences
after treatment of localised clear cell renal cell carcinoma (ccRCC) is unclear. This study …

Simple Summary Physicians routinely make individualized treatment decisions by
accounting for the joint effects of patient prognostic covariates and treatments on clinical …

Purpose Pretreatment measurements of systemic inflammatory response, including the
Glasgow prognostic score (GPS), the neutrophil-to-lymphocyte ratio (NLR), the monocyte-to …

Background: Robot-assisted partial nephrectomy (RAPN) is used more and more in present
days as a therapy option for surgical treatment of cT1 renal masses. Current guidelines …

Context Several studies suggest that body composition (ie, body proportions of muscle and
fat defined by computed tomography) is associated with clinical outcomes of several cancer …

Survival of patients with metastatic renal cell carcinoma (mRCC) has improved since the
advent of targeted therapy. Approved agents include the multi-targeted tyrosine kinase …

Purpose We sought to identify patterns and predictors of recurrence in patients with clinically
localized renal cell carcinoma managed by partial nephrectomy. Materials and Methods We …